Addressing Surgeon Hesitancy in Glaucoma Surgery

Patients are open to minimally invasive procedures when they are presented as alternatives to drops.

By: Inder Paul Singh, MD, Savak “Sev” Teymoorian, MD, MBA, Christine Funke, MD

Glaucoma Physician January 1, 2026 Page(s): 16-17, 20

Clinical Report: Addressing Surgeon Hesitancy in Glaucoma Surgery

Overview

This report highlights the hesitancy among ophthalmologists to recommend early surgical intervention for glaucoma despite evidence supporting its benefits. It emphasizes the need for a shift towards minimally invasive procedures as first-line treatments to improve patient outcomes and reduce treatment burdens.

Background

Glaucoma management has traditionally relied on topical drops, which are often poorly adhered to by patients, leading to unstable intraocular pressure (IOP) and disease progression. Recent studies suggest that early surgical intervention can significantly improve visual outcomes and reduce complications compared to delayed treatment. As the landscape of glaucoma therapy evolves, understanding the barriers to adopting minimally invasive surgical techniques is crucial for optimizing patient care.

Data Highlights

No specific numerical data provided in the article.

Key Findings

20% to 70% of glaucoma patients fail to adhere to prescribed drop regimens.
Delaying surgical intervention can restrict treatment options and complicate outcomes.
Minimally invasive glaucoma surgery (MIGS) has demonstrated low-risk profiles and consistent efficacy.
Selective laser trabeculoplasty (SLT) shows similar IOP-lowering benefits to drops without the associated side effects.
Procedural pharmaceuticals offer targeted IOP control, reducing the need for daily drops.
Early intervention can prevent disease progression and improve patient satisfaction.

Clinical Implications

Healthcare providers should reconsider the reliance on topical drops and advocate for early surgical interventions in glaucoma management. By informing patients about the benefits of minimally invasive procedures, clinicians can help them make better-informed decisions regarding their treatment options.

Conclusion

The transition from traditional drop therapy to early surgical intervention represents a critical shift in glaucoma management that can enhance patient outcomes and reduce the overall treatment burden. Addressing surgeon hesitancy is essential to realize the full potential of these advancements.

PentaVision

Glaucoma Physician